News

JinkoSolar's Subsidiary Shares Preliminary Financial Insights

JinkoSolar's Subsidiary Shares Preliminary Financial Insights

Introduction to JinkoSolar's Advanced Financial Estimates

JinkoSolar Holding Co., Ltd. is recognized as one of the largest solar module manufacturers in the world. With a commitment to innovation and sustainability, JinkoSolar consistently works towards enhancing its offerings and market presence. Recently, its majority-owned subsidiary, Jinko Solar Co., Ltd., known as Jiangxi Jinko, revealed estimates for preliminary unaudited financial results for the entire year 2024.

Financial Estimations and Concerns

When looking at the year ended, Jinko presents some concerning figures. The estimated net income attributable to shareholders of Jiangxi Jinko is projected to be between RMB80 million and RMB120 million. This represents a significant decrease from prior years, anywhere from 98.39% to 98.92%. Furthermore, the estimates indicate a substantial net loss concerning extraordinary gains and losses, ranging between RMB750 million to RMB1,050 million. Over the previous year, this change reflects a staggering drop of 110.86% to 115.21% in losses.

Differences in Financial Reporting

It is essential to note that the preliminary unaudited financial outcomes for Jiangxi Jinko differ from JinkoSolar's consolidated financial results. This discrepancy arises due to the various scopes of consolidation referenced in the reports. The consolidated results not only represent Jiangxi Jinko but also incorporate information from JinkoSolar and its subsidiaries. Additionally, these results are reported in accordance with different accounting standards; Jiangxi Jinko utilizes PRC GAAP while JinkoSolar adheres to accounting principles commonly accepted in the United States.

Ownership and Structural Details

JinkoSolar holds approximately 58.59% of the equity interest in Jiangxi Jinko. This ownership positions JinkoSolar strategically within the market, allowing it to leverage Jiangxi Jinko's operations and financial data to align with broader corporate strategies.

About JinkoSolar Holding Co., Ltd.

JinkoSolar is committed to delivering cutting-edge solar solutions across various sectors. With a robust distribution network, JinkoSolar extends its solar products to a diverse global customer base. These customers include utility companies, commercial enterprises, and residential clients, with notable operations in countries including the United States, Japan, Germany, and more.

Global Reach and Production Capabilities

Operating over 10 production facilities worldwide, JinkoSolar has established a significant international footprint. The company boasts more than 20 overseas subsidiaries in various countries, including Japan, South Korea, and several nations across Europe and Latin America. This extensive network enables JinkoSolar to effectively meet the growing demand for renewable energy solutions on a global scale.

Future Directions

As JinkoSolar continues to navigate the complex landscape of the solar industry, the preliminary unaudited financial results signal key insights into operational efficiency and market challenges. Investors are encouraged to consider these estimates diligently and assess their implications for investment strategies moving forward.

Frequently Asked Questions

What financial results did JinkoSolar's subsidiary announce?

Jinko Solar Co., Ltd. announced preliminary unaudited financial estimates for 2024, indicating a significant net loss and a drastic decrease in income compared to previous years.

How does JinkoSolar stand in the global market?

JinkoSolar is one of the largest solar module manufacturers, recognized for its innovative solutions and extensive international distribution network.

What are the implications of the different accounting standards?

The use of PRC GAAP for Jiangxi Jinko and U.S. GAAP for JinkoSolar can lead to discrepancies in financial reporting, impacting how investors interpret the financial data.

How much equity does JinkoSolar hold in Jiangxi Jinko?

JinkoSolar holds approximately 58.59% of the equity interest in its subsidiary, Jiangxi Jinko, which is crucial for its financial strategy.

Where can I find more information about JinkoSolar?

For more information, visit JinkoSolar's official website, where they provide updates on their products, services, and financial reports.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 154

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 122

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 207

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 22

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 225

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 155

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 150

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 233

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
les" class="btn" href="https://investorshangout.com/blog/news?page=2">More News Articles